These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30216783)

  • 1. Patterns of upper limb muscle activation in children with unilateral spastic cerebral palsy: Variability and detection of deviations.
    Sarcher A; Brochard S; Hug F; Letellier G; Raison M; Perrouin-Verbe B; Sangeux M; Gross R
    Clin Biomech (Bristol); 2018 Nov; 59():85-93. PubMed ID: 30216783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of muscle activation on ranges of motion during active elbow movement in children with spastic hemiplegic cerebral palsy.
    Sarcher A; Raison M; Ballaz L; Lemay M; Leboeuf F; Trudel K; Mathieu PA
    Clin Biomech (Bristol); 2015 Jan; 30(1):86-94. PubMed ID: 25467763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of pronator muscle overactivity in children with unilateral spastic cerebral palsy: Development of a semi-automatic method using EMG data.
    Sarcher A; Brochard S; Perrouin-Verbe B; Raison M; Letellier G; Leboeuf F; Gross R
    Ann Phys Rehabil Med; 2019 Nov; 62(6):409-417. PubMed ID: 31454560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological and physiological muscle co-activation during active elbow extension in children with unilateral cerebral palsy.
    Sarcher A; Raison M; Leboeuf F; Perrouin-Verbe B; Brochard S; Gross R
    Clin Neurophysiol; 2017 Jan; 128(1):4-13. PubMed ID: 27866118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004; (3):CD003469. PubMed ID: 15266487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Botulinum Toxin Type A Injection Followed by Rehabilitation in Cases of Cerebral Palsy With Upper Extremity Involvement.
    Karaca B; Ünlü E; Köse G; Gönen E; Çakcı A
    J Child Neurol; 2016 Mar; 31(3):357-63. PubMed ID: 26239492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for muscle activation during isometric torque generation at the human elbow.
    Buchanan TS; Rovai GP; Rymer WZ
    J Neurophysiol; 1989 Dec; 62(6):1201-12. PubMed ID: 2600619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involuntary and voluntary muscle activation in children with unilateral cerebral palsy--relationship to upper limb activity.
    Brændvik SM; Elvrum AK; Vereijken B; Roeleveld K
    Eur J Paediatr Neurol; 2013 May; 17(3):274-9. PubMed ID: 23201025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of neuromuscular activation of the upper limbs in children with spastic hemiparetic cerebral palsy during a dynamical task.
    Feltham MG; Ledebt A; Deconinck FJ; Savelsbergh GJ
    J Electromyogr Kinesiol; 2010 Jun; 20(3):448-56. PubMed ID: 19666231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications.
    Autti-Rämö I; Larsen A; Taimo A; von Wendt L
    Eur J Neurol; 2001 Nov; 8 Suppl 5():136-44. PubMed ID: 11851742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper extremity muscle activation in children with unilateral cerebral palsy during an auditory cued repetitive task: Effects on bimanual coordination.
    Charles J
    J Pediatr Rehabil Med; 2017; 10(1):19-26. PubMed ID: 28339407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of upper limb disability levels of children with spastic unilateral cerebral palsy using K-means algorithm.
    Raouafi S; Achiche S; Begon M; Sarcher A; Raison M
    Med Biol Eng Comput; 2018 Jan; 56(1):49-59. PubMed ID: 28667591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmented effects of EMG biofeedback interfaced with virtual reality on neuromuscular control and movement coordination during reaching in children with cerebral palsy.
    Yoo JW; Lee DR; Cha YJ; You SH
    NeuroRehabilitation; 2017; 40(2):175-185. PubMed ID: 28222541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy].
    Kurenkov AL; Klochkova OA; Bursagova BI; Karimova HM; Kuzenkova LM; Mamedyarov AM; Namazova-Baranova LS; Agranovich OV; Agranovich AO; Soboleva OA; Khapaeva MM; Batysheva TT; Sarzhina MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):37-44. PubMed ID: 29265085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of three-dimensional kinematic analysis following upper limb botulinum toxin A for children with hemiplegia.
    Mackey AH; Miller F; Walt SE; Waugh MC; Stott NS
    Eur J Neurol; 2008 Nov; 15(11):1191-8. PubMed ID: 18727674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat-treatment study.
    Delgado MR; Tilton A; Carranza-Del Río J; Dursun N; Bonikowski M; Aydin R; Maciag-Tymecka I; Oleszek J; Dabrowski E; Grandoulier AS; Picaut P;
    Dev Med Child Neurol; 2021 May; 63(5):592-600. PubMed ID: 33206382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An electromyographic study on the development of optimal tactics of botulinum toxin type A injections in children with spastic forms of cerebral palsy].
    Kurenkov AL; Kuzenkova LM; Burgasova BI; Petrova SA; Klochkova OA; Nikitin SS; Artemenko AR; Mamed'iarov AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5 Pt 2):53-60. PubMed ID: 23739515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.